Champions Oncology Inc (CSBR)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$4.80

-0.01 (-0.21%)

Market Cap: $66.95M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

52%(17/33)

Avg Surprise

+75.41%

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jul 31, 2026Jul 26 Reported Sep 10, 2026Reported Sep 10	$-0.03	$-0.01	-	-200.00%	Miss	-	-	-250.0%
Apr 30, 2026Apr 26 Reported Jul 27, 2026Reported Jul 27	$-0.05	$-0.05	$-0.05 - $-0.05	+0.00%	Beat	1	0 1 30d	+28.6%
Jan 31, 2026Jan 26 Reported Mar 12, 2026Reported Mar 12	$-0.02	N/A	-	-125.13%	Miss	1	1 0 30d	-106.1%
Oct 31, 2025Oct 25 Reported Dec 15, 2025Reported Dec 15	$0.06	$0.01	$0.01 - $0.01	+500.00%	Beat	1	0 1 30d	+20.0%
Jul 31, 2025Jul 25 Reported Sep 15, 2025Reported Sep 15	$0.02	$-0.01	$-0.01 - $-0.01	+300.00%	Beat	1	0 1 30d	-81.8%
Apr 30, 2025Apr 25 Reported Jul 23, 2025Reported Jul 23	$-0.07	$0.06	-	-216.67%	Miss	1	0 1 30d	-800.0%
Jan 31, 2025Jan 25 Reported Mar 11, 2025Reported Mar 11	$0.33	$-0.01	$-0.01 - $-0.01	+3400.00%	Beat	1	1 0 30d	+306.3%
Oct 31, 2024Oct 24 Reported Dec 11, 2024Reported Dec 11	$0.05	$0.01	$0.01 - $0.01	+400.00%	Beat	1	1 0 30d	+133.3%
Jul 31, 2024Jul 24 Reported Sep 11, 2024Reported Sep 11	$0.11	$-0.03	$-0.03 - $-0.03	+466.67%	Beat	1	No revisions (30d)	+168.8%
Apr 30, 2024Apr 24 Reported Jul 18, 2024Reported Jul 18	$0.01	N/A	-	+106.25%	Beat	1	No revisions (30d)	+105.3%
Jan 31, 2024Jan 24 Reported Mar 12, 2024Reported Mar 12	$-0.16	$-0.06	$-0.06 - $-0.06	-166.67%	Miss	1	1 0 30d	+0.0%
Oct 31, 2023Oct 23 Reported Dec 12, 2023Reported Dec 12	$-0.15	$-0.16	$-0.16 - $-0.16	+6.25%	Beat	2	No revisions (30d)	-1600.0%
Jul 31, 2023Jul 23 Reported Sep 13, 2023Reported Sep 13	$-0.16	$-0.10	$-0.10 - $-0.10	-60.00%	Miss	1	No revisions (30d)	-1500.0%
Apr 30, 2023Apr 23 Reported Jul 24, 2023Reported Jul 24	$-0.19	$-0.12	$-0.17 - $-0.08	-58.33%	Miss	2	No revisions (30d)	-533.3%
Jan 31, 2023Jan 23 Reported Mar 15, 2023Reported Mar 15	$-0.16	$-0.01	$-0.06 - $-0.01	-1500.00%	Miss	2	No revisions (30d)	-328.6%
Oct 31, 2022Oct 22 Reported Dec 13, 2022Reported Dec 13	$0.01	$0.02	$0.00 - $0.04	-50.00%	Miss	2	No revisions (30d)	-66.7%
Jul 31, 2022Jul 22 Reported Sep 8, 2022Reported Sep 8	$-0.01	$0.02	$0.02 - $0.02	-150.00%	Miss	2	No revisions (30d)	-200.0%
Apr 30, 2022Apr 22 Reported Jul 21, 2022Reported Jul 21	$-0.03	$0.03	$0.02 - $0.03	-200.00%	Miss	2	No revisions (30d)	+25.0%
Jan 31, 2022Jan 22 Reported Mar 15, 2022Reported Mar 15	$0.07	$0.04	$0.04 - $0.05	+75.00%	Beat	2	No revisions (30d)	+0.0%
Oct 31, 2021Oct 21 Reported Dec 13, 2021Reported Dec 13	$0.03	$0.02	$0.02 - $0.03	+50.00%	Beat	2	No revisions (30d)	+29900.0%
Jul 31, 2021Jul 21 Reported Sep 13, 2021Reported Sep 13	$0.01	$0.01	$0.01 - $0.01	+0.00%	Beat	1	No revisions (30d)	+0.0%
Apr 30, 2021Apr 21 Reported Jul 22, 2021Reported Jul 22	$-0.04	$0.00	$0.00 - $0.00	N/A	Beat	2	No revisions (30d)	+71.4%
Jan 31, 2021Jan 21 Reported Mar 11, 2021Reported Mar 11	$0.07	$0.01	$0.00 - $0.01	+600.00%	Beat	3	No revisions (30d)	+40.0%
Oct 31, 2020Oct 20 Reported Dec 14, 2020Reported Dec 14	$0.00	N/A	-	-99.00%	Miss	3	No revisions (30d)	-99.7%
Jul 31, 2020Jul 20 Reported Sep 14, 2020Reported Sep 14	$0.01	N/A	-	+133.33%	Beat	1	No revisions (30d)	+120.0%
Apr 30, 2020Apr 20 Reported Jul 27, 2020Reported Jul 27	$-0.14	$0.02	$0.01 - $0.02	-800.00%	Miss	2	No revisions (30d)	-1300.0%
Jan 31, 2020Jan 20 Reported Mar 12, 2020Reported Mar 12	$0.05	$0.03	$0.02 - $0.03	+66.67%	Beat	3	No revisions (30d)	+400.0%
Oct 31, 2019Oct 19 Reported Dec 16, 2019Reported Dec 16	$0.03	$0.01	$-0.04 - $0.01	+200.00%	Beat	3	No revisions (30d)	+0.0%
Jul 31, 2019Jul 19 Reported Sep 16, 2019Reported Sep 16	$-0.05	$0.02	$0.02 - $0.02	-350.00%	Miss	1	No revisions (30d)	-200.0%
Apr 30, 2019Apr 19 Reported Jul 15, 2019Reported Jul 15	$-0.01	N/A	-	-133.33%	Miss	1	No revisions (30d)	+75.0%
Jan 31, 2019Jan 19 Reported Mar 18, 2019Reported Mar 18	$0.01	N/A	-	-66.67%	Miss	3	No revisions (30d)	+200.0%
Oct 31, 2018Oct 18 Reported Dec 17, 2018Reported Dec 17	$0.03	$0.05	$0.05 - $0.05	-40.00%	Miss	0	No revisions (30d)	+400.0%
Jul 31, 2018Jul 18 Reported Sep 13, 2018Reported Sep 13	$0.05	$0.01	$0.01 - $0.01	+400.00%	Beat	1	No revisions (30d)	+183.3%
Apr 30, 2018Apr 18 Reported Jul 26, 2018Reported Jul 26	$-0.04	$-0.04	$-0.04 - $-0.03	+0.00%	Beat	2	No revisions (30d)	+73.3%
Jan 31, 2018Jan 18 Reported Mar 15, 2018Reported Mar 15	$-0.01	N/A	-	N/A	Beat	-	-	+90.9%
Oct 31, 2017Oct 17 Reported Dec 7, 2017Reported Dec 7	$-0.01	N/A	-	N/A	Beat	-	-	+78.3%
Jul 31, 2017Jul 17 Reported Sep 14, 2017Reported Sep 14	$-0.06	N/A	-	N/A	Beat	-	-	-
Apr 30, 2017Apr 17 Reported Jul 27, 2017Reported Jul 27	$-0.15	N/A	-	N/A	Beat	-	-	-
Jan 31, 2017Jan 17 Reported Mar 16, 2017Reported Mar 16	$-0.11	N/A	-	N/A	Beat	-	-	-
Oct 31, 2016Oct 16 Reported Nov 29, 2016Reported Nov 29	$-0.05	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-119.70	EV/EBITDA	141.38x
Price/FCF	-10.87x	FCF Yield	-9.20%
Profitability
Profit Margin	-1.87%	Operating Margin	-2.69%
ROE	-28.40%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	1.03x	Quick Ratio	1.03x
Trading Statistics
Beta	0.44	Avg Volume	12.39K
52-Week High	$8.31	52-Week Low	$4.59

Technical Indicators Dashboard

Moving Averages

SMA 10$4.91

SMA 20$4.97

SMA 50$5.01

SMA 200$5.86

EMA 10$4.89

EMA 20$4.94

EMA 50$5.10

EMA 200$5.76

MACD

Line: -0.07Signal: -0.06Hist: -0.01

ADX

ADX: 12.2+DI: 12.8-DI: 20.7

Aroon & PSAR

Aroon Up24.0

Aroon Down12.0

PSAR$5.51

Bollinger Bands

Upper Band$5.27

Lower Band$4.67

%B Position1216%(Upper)

Band Width0.22

RSI (14-Day)

Neutral

43.0

Momentum Oscillators

Stoch %K25.9

Stoch %D27.6

Williams %R-80.9

ROC (10d)-1.6%

Momentum-0.08

CCI (20d)-120.0

MFI (14d)46.8

Volatility Measures

ATR (14d)$0.21(4.3%)

StdDev (20d)0.15

Hist Vol38.6%(Moderate)

Volume Flow

VWAP$4.79

OBV-390.0K

AD Line-783.7K

CMF (20d)0.270

Volume Metrics

Avg Vol (20d)10.6K

Vol Ratio0.9x

VWMA (20d)$5.01

Pivot Points

R3$4.97

R2$4.92

R1$4.86

Pivot Point$4.81

S1$4.76

S2$4.71

S3$4.65

Advanced Oscillators

TSI-8.91

Ultimate Osc52.4

KST-25.42

Financial Data

Quarter	Jul 2026	Apr 2026	Jan 2026	Oct 2025	Jul 2025	Apr 2025	Jan 2025	Oct 2024	Jul 2024	Apr 2024	Jan 2024	Oct 2023
Total Revenue	$15.23M	$13.84M	$16.56M	$15.04M	$13.99M	$12.36M	$17.04M	$13.49M	$14.06M	$14.00M	$12.02M	$11.57M
Cost of Revenue	$7.53M	$6.81M	$8.83M	$7.26M	$8.00M	$7.27M	$6.62M	$7.43M	$7.07M	$7.25M	$7.85M	$6.62M
Gross Profit	$7.70M	$7.03M	$7.72M	$7.77M	$6.00M	$5.08M	$10.42M	$6.06M	$6.99M	$6.75M	$4.17M	$4.96M

Operating Expenses	$8.11M	$7.55M	$8.00M	$7.59M	$6.53M	$7.09M	$5.92M	$5.33M	$5.66M	$7.02M	$6.75M	$6.91M
R&D	$2.34M	$2.12M	$2.27M	$2.62M	$2.08M	$1.96M	$1.72M	$1.69M	$1.45M	$2.05M	$2.19M	$2.52M
SG&A	$2.67M	$2.63M	$2.98M	$2.97M	$2.57M	$2.52M	$2.40M	$1.89M	$2.53M	$2.76M	$2.76M	$2.60M
Operating Income	$-409,000	$-522,000	$-276,000	$185,000	$-527,000	$-2,007,000	$4.50M	$732,000	$1.33M	$-272,000	$-2,577,000	$-1,955,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$6,000	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$105,000
Income Before Tax	$-415,000	$-495,000	$-237,000	$255,000	$-452,000	$-1,965,000	$4.52M	$739,000	$1.33M	$-191,000	$-2,519,000	$-2,060,000
Income Tax Expense	$11,000	$172,000	$42,000	$18,000	$14,000	$-130,000	$23,000	$11,000	$21,000	$-82,000	$11,000	$11,000

Net Income	$-426,000	$-667,000	$-279,000	$237,000	$-466,000	$-1,835,000	$4.50M	$728,000	$1.31M	$-109,000	$-2,530,000	$-2,071,000

EBITDA	$-101,000	$-174,000	$104,000	$612,000	$-94,000	$-1,571,000	$4.92M	$1.14M	$1.78M	$266,000	$-2,038,000	$-1,576,000
EBIT	$-415,000	$-495,000	$-237,000	$255,000	$-452,000	$-1,965,000	$4.52M	$739,000	$1.33M	$-191,000	$-2,519,000	$-2,060,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about CSBR

News

Champions Oncology, Inc. (CSBR) Stock Price & News

Champions Oncology, Inc. (CSBR) stock is currently trading at US$4.95, up 2.34% as of October 12, 16:00 EDT, with a market capitalization of US$68.91 million. The company, founded in 1985...

Syfe•Oct 12, 2026 1:43 PM ET10/12/26•Somewhat-Bullish

Champions Oncology Q3 2026 Earnings Call Transcript

Champions Oncology reported record services revenue and a third consecutive quarter of positive adjusted EBITDA for Q3 2026...

Benzinga•Oct 8, 2026 9:42 AM ET10/8/26•Somewhat-Bullish

Champions Oncology Q3FY26 Results: Services revenue up 32% to $16.6m

Champions Oncology reported record Q3FY26 services revenue of $16.6 million, a 32% year-over-year increase, despite a slight overall revenue decline due to the absence of data revenue. The company achieved its third...

scanx.trade•Oct 8, 2026 9:42 AM ET10/8/26•Neutral

Full Transcript: Champions Oncology Q1 2027 Earnings Call

Champions Oncology (NASDAQ: CSBR) reported its Q1 2027 earnings, with CEO Rob Brainin highlighting that the company is moving in the right direction after an investment year in fiscal 2026. Revenue reached $15.2 million...

Benzinga•Oct 8, 2026 9:42 AM ET10/8/26•Bullish

Champions Oncology Q4 2026 Earnings Call Transcript

Champions Oncology reported record annual revenue of $59.4 million for fiscal 2026, a 12% increase driven by its core Translational Oncology Services (TOS) business...

Benzinga•Oct 8, 2026 9:42 AM ET10/8/26•Bullish

CSBR Valuation and Fair Value

P/E: -119.7x
Forward P/E: 22.9x
EV/EBITDA: 141.4x
P/FCF: -10.9x
PEG: 0.0x
P/B: 17.1x

See GNG's fair value

CSBR Profitability: Margins, ROIC and FCF

Gross margin: 49.8%
Operating margin: -2.7%
Net margin: -1.9%
ROE: -28.4%
FCF margin: -10.1%
FCF yield: -9.2%

CSBR Competitors

Company	Ticker
Spero Therapeutics Inc	SPRO
Neumora Therapeutics, Inc.	NMRA
Microbot Medical Inc	MBOT
XBiotech Inc	XBIT
Cingulate Inc	CING
Verrica Pharmaceuticals Inc	VRCA
Heron Therapeuti	HRTX
Rein Therapeutics Inc	RNTX

Sector: Healthcare

CSBR Bull Case vs Bear Case

Bear case

CSBR has a -1.9% net profit margin.

CSBR Earnings: Beat Rate and Next Report

Beat rate: 4 of 8 quarters (50.0%)
Average surprise: 507.3%

Frequently Asked Questions About CSBR

Does CSBR pay dividends?

Champions Oncology Inc (CSBR) does not currently pay a regular dividend.

What is CSBR's market cap?

Champions Oncology Inc (CSBR) has a market capitalization of $66.95M with a current stock price of $4.80.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In